STAMFORD, Conn., Nov. 1 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. announced today it has retained the public relations and investor relations services of KCSA Worldwide, a leading New York-based communications firm, to implement a comprehensive communications campaign.
M. S. Koly, chief executive officer, stated, “Delcath is one of the few companies granted fast-track status by the FDA in 2005, which we received for our Delcath system when used with melphalan for the treatment of liver cancer. As such, we understand the importance of increasing communications with our shareholders as we move ahead, and look forward to working with KCSA to expand awareness and communicate our strategy for long-term success.”
Todd Fromer, Managing Partner of KCSA Worldwide, stated, “We are excited to work with Delcath. The Company presents a compelling story and management has expressed a strong commitment to increase awareness among its core constituents. We look forward to providing our integrated IR and PR services in support of Delcath’s communications initiatives.”
About KCSA Worldwide
KCSA Public Relations Worldwide is a leading public and investor relations firm with practice areas in public relations, investor relations, corporate and marketing communications, and design and graphics. KCSA is the U.S. partner of European Communication Partners, a network of public relations firms in EEC countries and Canada, and the U.S. member of IR Asia-Pacific Ltd., the world’s first network of independent investor relations consultancies. The firm has strategic alliances in Australia, Israel, Russia and South America.
About Delcath Systems, Inc.
Delcath Systems is a developer of isolated perfusion technology for organ or region-specific delivery of therapeutic agents. Six US and three foreign issued patents cover its technology. The company is headquartered in Stamford, CT.
This release contains “forward-looking statements” based on current expectations but involving known and unknown risks and uncertainties. Actual results or achievements may be materially different from those expressed or implied. Delcath plans and objectives are based on assumptions involving judgments with respect to future economic, competitive and market conditions, its ability to consummate, and the timing of, acquisitions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond its control. Therefore, there can be no assurance than any forward-looking statement will prove to be accurate.
Delcath Systems, Inc.
CONTACT: M. S. Koly, Chief Executive Officer of Delcath Systems, Inc.,+1-203-323-8668; or Michael Cimini, +1-212-896-1233, mcimini@kcsa.com, orLewis Goldberg, +1-212-896-1216, lgoldberg@kcsa.com, both of KCSA Worldwide
Web site: http://www.delcath.com/
